VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2022
Vivo Bio Tech Limited has informed the exchange that the Board of Directors of the Company at their meeting held today, i.e. Monday, November 14, 2022, approved the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2022. VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2022.
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2022. VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Vivo Bio Tech Limited has submitted with the exchange Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the period from July 01, 2022 to September 30, 2022. VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Vivo Bio Tech Limited has informed the exchange that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Company's Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from October 01, 2022 till the end of 48 hours after the declaration of the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2022. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Vivo Bio Tech Limited has informed the exchange that the members of the Company have approved the resolution for shifting of registered office of the Company from Survey #349/A, Pregnapur Village, Gajwel, Siddipet District, Hyderabad, Telangana - 502311 to 03rd Floor, Ilyas Mohammed Khan Estate, #8-2-672/ 5 & 6, Road No.1, Banjara Hills, Hyderabad, Telangana - 500034, at the 35th Annual General Meeting of the Company held on September 28, 2022 through video conference. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Vivo Bio Tech Limited has informed the exchange that the members of the Company have appointed M/s P Murali & Co (FRN 007257S), Chartered Accounts as the Statutory Auditors of the Company at the 35th Annual General Meeting of the Company held on September 28, 2022 through video conference. VIVO BIO TECH LTD. - 511509 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Vivo Bio Tech Limited has submitted with the exchange the Voting Results and Scrutinizers Report for the resolutions passed by the members of the Company at the 35th Annual General Meeting held on September 28, 2022 through Video Conference. VIVO BIO TECH LTD. - 511509 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Vivo Bio Tech Limited has submitted with the exchange the Proceedings of the 35th Annual General Meeting of the Company held on Wednesday, September 28, 2022 at 03.00 pm through video conference. VIVO BIO TECH LTD. - 511509 - Clarification On Price Movement
Vivo Bio Tech Limited has submitted with the exchange the Clarification on Price Movement in connection with email received from BSE on September 06, 2022. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Vivo Bio Tech Limited has submitted with the exchange the copies of Newspaper Publication for Notice of 35th Annual General Meeting, Book Closure and E-Voting.